Roth/MKM Reiterates Buy Rating on TFF Pharmaceuticals (TFFP) Sep 26, 2024 12:08PM
TFF Pharmaceuticals Inc. (TFFP) Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID Sep 11, 2024 07:00AM
TFF Pharmaceuticals (TFFP) Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization Sep 10, 2024 07:00AM
TFF Pharmaceuticals Inc. (TFFP) Provides Continued Positive Outcomes from TFF TAC Phase 2 Trial for the Prevention of Lung Transplant Rejection Aug 6, 2024 08:01AM
TFF Pharmaceuticals Inc. (TFFP) Engages Outcome Capital as a Strategic Advisor for Evaluating Partnership and Licensing Opportunities Jun 26, 2024 07:02AM


Jun 24, 2024 07:04AM TFF Pharmaceuticals (TFFP) Provides Regulatory Update on Tacrolimus Inhalation Powder (TFF TAC) Clinical Program for the Prevention of Lung Transplant Rejection